PRKDC and cancer: Additionally, comprehensive correlation analysis between Prkdc mutations, TMB, the tumor microenvironment, and treatment outcomes in patients with various types of cancer who underwent ICI therapy showed Prkdc mutations were significantly linked to elevated TMB and an inflammatory tumor microenvironment.